| 4.74 -0.03 (-0.63%) | 08-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.46 |
1-year : | 15.18 |
| Resists | First : | 9.81 |
Second : | 13 |
| Pivot price | 5.84 |
|||
| Supports | First : | 4.65 |
Second : | 3.87 |
| MAs | MA(5) : | 5.22 |
MA(20) : | 5.89 |
| MA(100) : | 13.11 |
MA(250) : | 23.71 |
|
| MACD | MACD : | -1.2 |
Signal : | -1.2  |
| %K %D | K(14,3) : | 4.2 |
D(3) : | 10.5 |
| RSI | RSI(14): 24.9 |
|||
| 52-week | High : | 45.33 | Low : | 4.65 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SNWV ] has closed below the lower bollinger band by 3.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SNWV ] is to continue within current trading range. It is unclear right now based on current values. 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.08 - 5.13 | 5.13 - 5.16 |
| Low: | 4.56 - 4.62 | 4.62 - 4.65 |
| Close: | 4.67 - 4.77 | 4.77 - 4.83 |
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Fri, 14 Aug 2026
Solas Capital discloses 7.1% SANUWAVE Health (SNWV) position via managed funds - Stock Titan
Fri, 07 Aug 2026
Sanuwave Health Q2 Earnings Call Highlights - TradingView
Fri, 07 Aug 2026
SANUWAVE Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SNWV) 2026-08-07 - Seeking Alpha
Fri, 07 Aug 2026
Sanuwave Health (SNWV) to Release Quarterly Earnings on Friday - MarketBeat
Thu, 06 Aug 2026
Is SANUWAVE Health Inc (SNWV) a Value Opportunity After Q2 Earni - GuruFocus
Thu, 06 Aug 2026
Earnings To Watch: SANUWAVE Health Inc (SNWV) Q2 2026 -- GF Value Sees 166% Upside - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 9 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 35.3 (%) |
| Shares Short | 615 (K) |
| Shares Short P.Month | 770 (K) |
| EPS | 0.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | 33.5 % |
| Operating Margin | -2.9 % |
| Return on Assets (ttm) | 4.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -4.2 % |
| Gross Profit (p.s.) | 3.89 |
| Sales Per Share | 5.1 |
| EBITDA (p.s.) | 0.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | 5.85 |
| PEG Ratio | 0 |
| Price to Book value | 22.57 |
| Price to Sales | 0.92 |
| Price to Cash Flow | 7.8 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|